
AbbVie Inc. ownership: holders and insider trading
$295.03+0.20%Close 13 Nov 2026 · Market value $524.5B
As filed, its directors and officers own 0.1% of the shares (proxy statement, 6 Mar 2026); 4,163 institutional managers reported holding 75.4% at 30 Jun 2026. Over the last twelve months, insiders sold $30.85M of shares on the open market, $9.52M of it under 10b5-1 plans set in advance, and bought none.
From the company's proxy statement, each holder's latest Schedule 13D or 13G, the institutional managers' quarterly 13F reports and the insiders' Form 4 filings. A percentage is shown as filed; one marked * is worked out here from the shares outstanding.
Largest holders
| Holder | Type | Shares | Of the company | Source | As of |
|---|
| The Vanguard Group | Holder | 183M | 10.35%* | Form 13F | 30 Jun 2026 |
|---|
| BlackRock, Inc. | Holder | 149M | 8.46%* | Form 13F | 30 Jun 2026 |
|---|
| Vanguard Capital Management | Holder | 133M | 7.51% | Schedule 13G | 31 Mar 2026 |
|---|
| State Street | Institution | 82.6M | 4.67%* | Form 13F | 30 Jun 2026 |
|---|
| Capital Group | Institution | 65.0M | 3.68%* | Form 13F | 30 Jun 2026 |
|---|
| JPMorgan Chase | Institution | 47.9M | 2.71%* | Form 13F | 30 Jun 2026 |
|---|
| Geode Capital Management | Institution | 47.0M | 2.66%* | Form 13F | 30 Jun 2026 |
|---|
| Morgan Stanley | Institution | 38.9M | 2.20%* | Form 13F | 30 Jun 2026 |
|---|
| UBS | Institution | 27.1M | 1.53%* | Form 13F | 30 Jun 2026 |
|---|
| Norges Bank | Institution | 25.6M | 1.45%* | Form 13F | 30 Jun 2026 |
|---|
| Bank of America | Institution | 21.2M | 1.20%* | Form 13F | 30 Jun 2026 |
|---|
| Fidelity (FMR) | Institution | 20.8M | 1.18%* | Form 13F | 30 Jun 2026 |
|---|
| Northern Trust | Institution | 20.6M | 1.16%* | Form 13F | 30 Jun 2026 |
|---|
| Franklin Templeton | Institution | 19.9M | 1.13%* | Form 13F | 30 Jun 2026 |
|---|
| Goldman Sachs | Institution | 16.3M | 0.92%* | Form 13F | 30 Jun 2026 |
|---|
| T. Rowe Price | Institution | 14.8M | 0.83%* | Form 13F | 30 Jun 2026 |
|---|
| Charles Schwab | Institution | 12.9M | 0.73%* | Form 13F | 30 Jun 2026 |
|---|
| BNY | Institution | 12.9M | 0.73%* | Form 13F | 30 Jun 2026 |
|---|
| Legal & General | Institution | 11.5M | 0.65%* | Form 13F | 30 Jun 2026 |
|---|
| Ameriprise | Institution | 11.5M | 0.65%* | Form 13F | 30 Jun 2026 |
|---|
Insider transactions latest 25
| Insider | Date | Transaction | Shares | Price | Value |
|---|
| Stewart Jeffrey Ryan · EVP, CHIEF COMMERCIAL OFFICER | 9 Nov 2026 | Option exercise | +16.1K | $114.36 | $1.84M |
|---|
| Stewart Jeffrey Ryan · EVP, CHIEF COMMERCIAL OFFICER | 9 Nov 2026 | Option exercise | +24.5K | $93.50 | $2.30M |
|---|
| Stewart Jeffrey Ryan · EVP, CHIEF COMMERCIAL OFFICER | 9 Nov 2026 | Open-market sale | −40.6K | $293.60 | $11.93M |
|---|
| Donoghoe Nicholas · EVP, CHIEF BUS/STRAT OFFICER | 14 Aug 2026 | Option exercise | +32.7K | $79.02 | $2.58M |
|---|
| Donoghoe Nicholas · EVP, CHIEF BUS/STRAT OFFICER | 14 Aug 2026 | Open-market sale | −32.7K | $250.00 | $8.18M |
|---|
| Quaggin Susan E · Director | 8 May 2026 | Grant or award | +1.1K | — | — |
|---|
| Davis Jennifer L. · Director | 8 May 2026 | Grant or award | +1.1K | — | — |
|---|
| MEYER MELODY B · Director | 8 May 2026 | Grant or award | +1.1K | — | — |
|---|
| BURNSIDE WILLIAM H.L. · Director | 8 May 2026 | Grant or award | +1.1K | — | — |
|---|
| Hart Brett J · Director | 8 May 2026 | Grant or award | +1.1K | — | — |
|---|
| Roberts Rebecca B · Director | 8 May 2026 | Grant or award | +1.1K | — | — |
|---|
| FREYMAN THOMAS C · Director | 8 May 2026 | Grant or award | +1.1K | — | — |
|---|
| WADDELL FREDERICK H · Director | 8 May 2026 | Grant or award | +1.1K | — | — |
|---|
| FALK THOMAS J · Director | 8 May 2026 | Grant or award | +1.1K | — | — |
|---|
| RAPP EDWARD J · Director | 8 May 2026 | Grant or award | +1.1K | — | — |
|---|
| AUSTIN ROXANNE S · Director | 8 May 2026 | Grant or award | +1.1K | — | — |
|---|
| Purdue David Ryan · SVP, Controller | 4 Mar 2026 | Open-market sale | −5.2K | $233.56 | $1.22M |
|---|
| Siatis Perry C · EVP, GC AND SECRETARY | 2 Mar 2026 | Open-market sale (10b5-1 plan) | −10.3K | $234.66 | $2.41M |
|---|
| Siatis Perry C · EVP, GC AND SECRETARY | 2 Mar 2026 | Open-market sale (10b5-1 plan) | −2.6K | $235.26 | $611.7K |
|---|
| Siatis Perry C · EVP, GC AND SECRETARY | 2 Mar 2026 | Open-market sale (10b5-1 plan) | −5.8K | $233.51 | $1.35M |
|---|
| Purdue David Ryan · SVP, Controller | 27 Feb 2026 | Shares withheld for tax | −2.1K | $232.08 | $489.2K |
|---|
| Crum Demetris D · EVP, CHIEF HR OFFICER | 27 Feb 2026 | Shares withheld for tax | −1.6K | $232.08 | $369.9K |
|---|
| Thakkar Roopal · EVP, R&D and CSO | 27 Feb 2026 | Shares withheld for tax | −8.0K | $232.08 | $1.87M |
|---|
| Siatis Perry C · EVP, GC AND SECRETARY | 27 Feb 2026 | Shares withheld for tax | −14.8K | $232.08 | $3.45M |
|---|
| Reents Scott T · EVP, CHIEF FINANCIAL OFFICER | 27 Feb 2026 | Shares withheld for tax | −21.6K | $232.08 | $5.02M |
|---|
Form 4 filings since 16 Nov 2024: purchases and sales, grants, option exercises and shares withheld for tax. Gifts and other transfers are left out.
ABBV in the terminal
Holders over eight quarters by family, every Form 4 and Form 144 back two years, and alerts on insider buying.